West Pharmaceutical Services Stock Price, News & Analysis (NYSE:WST)

$99.08 -0.55 (-0.55 %)
(As of 12/11/2017 04:00 PM ET)
Previous Close$99.63
Today's Range$98.98 - $99.65
52-Week Range$77.97 - $103.36
Volume175,396 shs
Average Volume361,198 shs
Market Capitalization$7.40 billion
P/E Ratio42.94
Dividend Yield0.56%
Beta1.11

About West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services logoWest Pharmaceutical Services, Inc. is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company's products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services. The Company's segments include Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment develops commercial and operational strategies across its global network, with specific emphasis on product offerings to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as an integrated business focused on the design, manufacture and automated assembly of various devices, primarily for pharmaceutical, diagnostic and medical device customers.

Receive WST News and Ratings via Email

Sign-up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNYSE:WST
CUSIP95530610
Phone610-594-2900

Debt

Debt-to-Equity Ratio0.15%
Current Ratio2.59%
Quick Ratio1.87%

Price-To-Earnings

Trailing P/E Ratio42.94
Forward P/E Ratio35.90
P/E Growth2.12

Sales & Book Value

Annual Sales$1.51 billion
Price / Sales4.87
Cash Flow$3.45 per share
Price / Cash28.69
Book Value$15.27 per share
Price / Book6.49

Profitability

Trailing EPS$2.51
Net Income$143.60 million
Net Margins12.12%
Return on Equity14.47%
Return on Assets9.71%

Miscellaneous

Employees7,100
Outstanding Shares74,250,000

West Pharmaceutical Services (NYSE:WST) Frequently Asked Questions

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services announced a quarterly dividend on Thursday, July 20th. Investors of record on Wednesday, October 18th will be paid a dividend of $0.14 per share on Wednesday, November 1st. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.57%. The ex-dividend date of this dividend is Tuesday, October 17th. This is a boost from West Pharmaceutical Services's previous quarterly dividend of $0.13. View West Pharmaceutical Services' Dividend History.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services, Inc. (NYSE:WST) announced its quarterly earnings results on Thursday, October, 26th. The medical instruments supplier reported $0.67 earnings per share for the quarter, topping analysts' consensus estimates of $0.53 by $0.14. The medical instruments supplier earned $398.20 million during the quarter, compared to the consensus estimate of $386.02 million. West Pharmaceutical Services had a net margin of 12.12% and a return on equity of 14.47%. The company's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter last year, the business earned $0.53 EPS. View West Pharmaceutical Services' Earnings History.

When will West Pharmaceutical Services make its next earnings announcement?

West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Wednesday, February, 14th 2018. View Earnings Estimates for West Pharmaceutical Services.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services updated its FY17 earnings guidance on Thursday, October, 26th. The company provided earnings per share (EPS) guidance of $2.74-2.79 for the period, compared to the Thomson Reuters consensus estimate of $2.62. The company issued revenue guidance of $1.595-1.605 billion, compared to the consensus revenue estimate of $1.59 billion.

Where is West Pharmaceutical Services' stock going? Where will West Pharmaceutical Services' stock price be in 2017?

5 brokerages have issued 12-month price objectives for West Pharmaceutical Services' shares. Their forecasts range from $98.00 to $115.00. On average, they anticipate West Pharmaceutical Services' share price to reach $106.00 in the next year. View Analyst Ratings for West Pharmaceutical Services.

What are Wall Street analysts saying about West Pharmaceutical Services stock?

Here are some recent quotes from research analysts about West Pharmaceutical Services stock:

  • 1. According to Zacks Investment Research, "West Pharmaceutical Services applies technologies to the process of bringing new drug therapies and healthcare products. West's technologies include the design and manufacture of packaging components for pharmaceutical, healthcare and consumer products; research and development of drug delivery systems; contract manufacturing and packaging services; clinical services; and contract laboratory services and other services that support the manufacturing, filling and packaging of pharmaceutical, healthcare and consumer products. " (9/27/2017)
  • 2. Jefferies Group LLC analysts commented, "WST's formal '17 guidance featured a 1% higher CC revenue growth (7-9% from 6-8%) and continued margin expansion driven by high-value product growth. But that wasn't enough. At 33x '17, we thought the market discounted inflecting EPS growth, which has made valuation look stretched to us. FX headwinds ($35-45M; $0.05-0.07) and slightly rising tax rate negate the faster top-line. Maintain Hold." (2/21/2017)

Who are some of West Pharmaceutical Services' key competitors?

Who are West Pharmaceutical Services' key executives?

West Pharmaceutical Services' management team includes the folowing people:

  • Eric Mark Green, President, Chief Executive Officer, Director (Age 47)
  • William J. Federici, Chief Financial Officer, Senior Vice President, Treasurer (Age 57)
  • Annette F. Favorite, Chief Human Resource Officer, Senior Vice President (Age 52)
  • George Lloyd Miller J.D., Senior Vice President, General Counsel, Corporate Secretary (Age 62)
  • Karen A. Flynn, Senior Vice President and Chief Commercial Officer (Age 54)
  • David A. Montecalvo, Senior Vice President - Global Operations and Supply Chain (Age 51)
  • Eric Resnick, Chief Technology Officer, Vice President (Age 53)
  • Daniel Malone, Vice President, Corporate Controller (Age 55)
  • Michael A. Anderson, Vice President, Treasurer (Age 61)
  • Patrick J. Zenner, Non-Executive Independent Chairman of the Board (Age 70)

Who owns West Pharmaceutical Services stock?

West Pharmaceutical Services' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Neuberger Berman Group LLC (4.87%), JPMorgan Chase & Co. (2.49%), Fisher Asset Management LLC (1.44%), Hermes Investment Management Ltd. (1.23%), Eagle Asset Management Inc. (1.20%) and Bank of New York Mellon Corp (1.17%). Company insiders that own West Pharmaceutical Services stock include Daniel Malone, Heino Lennartz, Karen Flynn, Michael A Anderson, Patrick J Zenner, Paula A Johnson, Thomas W Hofmann, Warwick Bedwell and William J Federici. View Institutional Ownership Trends for West Pharmaceutical Services.

Who sold West Pharmaceutical Services stock? Who is selling West Pharmaceutical Services stock?

West Pharmaceutical Services' stock was sold by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., JPMorgan Chase & Co., Neuberger Berman Group LLC, Prudential Financial Inc., Fisher Asset Management LLC, Allianz Asset Management GmbH, GHP Investment Advisors Inc. and Nationwide Fund Advisors. Company insiders that have sold West Pharmaceutical Services company stock in the last year include Daniel Malone and William J Federici. View Insider Buying and Selling for West Pharmaceutical Services.

Who bought West Pharmaceutical Services stock? Who is buying West Pharmaceutical Services stock?

West Pharmaceutical Services' stock was acquired by a variety of institutional investors in the last quarter, including Artisan Partners Limited Partnership, TCW Group Inc., Janus Henderson Group PLC, AGF Investments Inc., Jennison Associates LLC, Teacher Retirement System of Texas, Victory Capital Management Inc. and American Century Companies Inc.. View Insider Buying and Selling for West Pharmaceutical Services.

How do I buy West Pharmaceutical Services stock?

Shares of West Pharmaceutical Services can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is West Pharmaceutical Services' stock price today?

One share of West Pharmaceutical Services stock can currently be purchased for approximately $99.08.

How big of a company is West Pharmaceutical Services?

West Pharmaceutical Services has a market capitalization of $7.40 billion and generates $1.51 billion in revenue each year. The medical instruments supplier earns $143.60 million in net income (profit) each year or $2.51 on an earnings per share basis. West Pharmaceutical Services employs 7,100 workers across the globe.

How can I contact West Pharmaceutical Services?

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected]


MarketBeat Community Rating for West Pharmaceutical Services (WST)

Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  93 (Vote Outperform)
Underperform Votes:  196 (Vote Underperform)
Total Votes:  289
MarketBeat's community ratings are surveys of what our community members think about West Pharmaceutical Services and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

West Pharmaceutical Services (NYSE:WST) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.602.602.672.67
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $99.31$99.31$81.28$81.28
Price Target Upside: 1.61% downside1.61% downside18.27% downside18.27% downside

West Pharmaceutical Services (NYSE:WST) Consensus Price Target History

Price Target History for West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services (NYSE:WST) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/27/2017Wells Fargo & CompanyBoost Price TargetOutperform$105.00 -> $112.00N/AView Rating Details
10/17/2017Bank of AmericaDowngradeBuy -> Neutral$98.00N/AView Rating Details
10/3/2017StephensInitiated CoverageEqual -> Equal Weight$99.00MediumView Rating Details
9/15/2017Jefferies GroupUpgradeHold -> Buy$96.00 -> $115.00HighView Rating Details
12/23/2016Janney Montgomery ScottReiterated RatingBuyN/AView Rating Details
(Data available from 12/11/2015 forward)

Earnings

West Pharmaceutical Services (NYSE:WST) Earnings History and Estimates Chart

Earnings by Quarter for West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services (NYSE WST) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/14/2018$0.63N/AView Earnings Details
10/26/2017Q3 2017$0.53$0.67$386.02 million$398.20 millionViewN/AView Earnings Details
7/27/2017Q2 2017$0.65$0.66$406.00 million$397.60 millionViewN/AView Earnings Details
4/27/2017Q1 2017$0.55$0.81$380.42 million$387.70 millionViewN/AView Earnings Details
2/16/2017Q416$0.56$0.54$387.31 million$382.30 millionViewListenView Earnings Details
10/27/2016Q316$0.53$0.53$371.76 million$376.70 millionViewListenView Earnings Details
7/28/2016Q216$0.56$0.59$384.58 million$388.00 millionViewListenView Earnings Details
4/28/2016Q116$0.51$0.53$355.86 million$362.10 millionViewListenView Earnings Details
2/18/2016Q415$0.47$0.47$364.76 million$359.70 millionViewListenView Earnings Details
10/29/2015Q315$0.43$0.44$355.90 million$344.50 millionViewListenView Earnings Details
7/30/2015Q215$0.45$0.47$356.33 million$359.70 millionViewListenView Earnings Details
4/30/2015Q115$0.40$0.45$346.64 million$335.90 millionViewListenView Earnings Details
2/19/2015Q414$0.46$0.45$348.33 million$349.80 millionViewListenView Earnings Details
10/30/2014Q314$0.43$0.44$356.08 million$355.90 millionViewListenView Earnings Details
7/31/2014Q214$0.47$0.52$368.60 million$368.90 millionViewN/AView Earnings Details
5/1/2014Q114$0.41$0.38$340.90 million$346.80 millionViewListenView Earnings Details
2/20/2014Q413$0.38$0.38$348.70 million$342.70 millionViewListenView Earnings Details
10/31/2013Q3 13$0.36$0.39$333.25 million$341.80 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.82$0.86$349.85 million$344.50 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.86$0.87$344.20 million$339.40 millionViewListenView Earnings Details
2/21/2013Q4 2012$0.56$0.61$318.75 million$321.50 millionViewListenView Earnings Details
11/1/2012Q312$0.50$0.52$306.91 million$303.80 millionViewN/AView Earnings Details
8/2/2012$0.69$0.79ViewN/AView Earnings Details
4/26/2012$0.65$0.83ViewN/AView Earnings Details
2/16/2012$0.55$0.59ViewN/AView Earnings Details
11/1/2011$0.54$0.53ViewN/AView Earnings Details
7/28/2011$0.68$0.62ViewN/AView Earnings Details
4/28/2011$0.62$0.60ViewN/AView Earnings Details
2/17/2011$0.46$0.42ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

West Pharmaceutical Services (NYSE:WST) Earnings Estimates

2017 EPS Consensus Estimate: $2.30
2018 EPS Consensus Estimate: $3.01
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.55$0.55$0.55
Q2 20171$0.59$0.59$0.59
Q3 20171$0.54$0.54$0.54
Q4 20171$0.62$0.62$0.62
Q1 20181$0.82$0.82$0.82
Q2 20181$0.81$0.81$0.81
Q3 20181$0.68$0.68$0.68
Q4 20181$0.70$0.70$0.70
(Data provided by Zacks Investment Research)

Dividends

West Pharmaceutical Services (NYSE:WST) Dividend Information

Most Recent Dividend:11/1/2017
Annual Dividend:$0.56
Dividend Yield:0.57%
Dividend Growth:8.40% (3 Year Average)
Payout Ratio:22.31% (Trailing 12 Months of Earnings)
20.29% (Based on This Year's Estimates)
19.44% (Based on Next Year's Estimates)
Track Record:24 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services (NYSE:WST) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/20/2017Quarterly$0.140.6%10/17/201710/18/201711/1/2017
5/16/2017quarterly$0.130.54%7/17/20177/19/20178/2/2017
2/16/2017Quarterly$0.134/17/20174/19/20175/3/2017
12/14/2016quarterly$0.130.61%1/13/20171/18/20172/1/2017
9/12/2016quarterly$0.1310/17/201610/19/201611/2/2016
7/6/2016Quarterly$0.127/18/20167/20/20168/3/2016
3/4/2016Quarterly$0.124/18/20164/20/20165/4/2016
12/17/2015Quarterly$0.121/15/20161/20/20162/3/2016
7/15/2015quarterly$0.120.79%10/19/201510/21/201511/4/2015
7/2/2015quarterly$0.110.76%7/20/20157/22/20158/5/2015
2/20/2015quarterly$0.110.82%4/20/20154/22/20155/6/2015
12/22/2014quarterly$0.110.81%1/16/20151/21/20152/4/2015
7/16/2014quarterly$0.1110/20/201410/22/201411/5/2014
7/16/2014quarterly$0.111.11%10/15/201410/19/201411/3/2014
5/8/2014quarterly$0.100.94%7/21/20147/23/20148/6/2014
2/20/2014quarterly$0.100.83%4/21/20144/23/20145/7/2014
12/19/2013quarterly$0.100.81%1/17/20141/22/20142/5/2014
8/1/2013quarterly$0.2010/23/201311/6/2013
5/10/2013quarterly$0.191.16%7/22/20137/24/20138/7/2013
3/15/2013quarterly$0.191.21%4/15/20134/17/20135/1/2013
12/27/2012quarterly$0.191.4%1/18/20131/23/20132/6/2013
(Data available from 1/1/2013 forward)

Insider Trades

West Pharmaceutical Services (NYSE WST) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.90%
Institutional Ownership Percentage: 93.28%
Insider Trades by Quarter for West Pharmaceutical Services (NYSE:WST)
Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services (NYSE WST) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/18/2017William J. FedericiCFOSell54,996$95.45$5,249,368.20View SEC Filing  
5/2/2017Daniel MaloneVPSell4,124$93.31$384,810.44View SEC Filing  
12/8/2016Patrick J. ZennerDirectorBuy332$84.53$28,063.96View SEC Filing  
10/31/2016Paula A. JohnsonDirectorSell2,466$75.87$187,095.42View SEC Filing  
9/6/2016Karen FlynnSVPSell14,581$83.28$1,214,305.68View SEC Filing  
8/23/2016Paula A JohnsonDirectorSell3,042$81.55$248,075.10View SEC Filing  
6/2/2016Daniel MaloneVPSell3,950$74.95$296,052.50View SEC Filing  
5/25/2016Thomas W HofmannDirectorSell2,466$73.57$181,423.62View SEC Filing  
3/1/2016Michael A AndersonVPSell16,414$63.58$1,043,602.12View SEC Filing  
2/29/2016Thomas W HofmannDirectorSell3,042$62.70$190,733.40View SEC Filing  
2/25/2016Heino LennartzInsiderSell5,680$62.47$354,829.60View SEC Filing  
2/24/2016Heino LennartzInsiderSell19,658$59.45$1,168,668.10View SEC Filing  
2/23/2016Paula A. JohnsonDirectorSell7,800$59.39$463,242.00View SEC Filing  
2/22/2016Warwick BedwellInsiderSell16,042$59.52$954,819.84View SEC Filing  
11/25/2015John E. PaproskiinsiderSell17,560$63.41$1,113,479.60View SEC Filing  
11/12/2015Heino LennartzInsiderSell3,500$61.87$216,545.00View SEC Filing  
11/6/2015Michael A AndersonVPSell3,000$62.18$186,540.00View SEC Filing  
11/5/2015Michael A. AndersonVPSell10,000$61.98$619,800.00View SEC Filing  
11/4/2015Daniel MaloneVPSell4,456$61.65$274,712.40View SEC Filing  
8/17/2015William J FedericiCFOSell52,678$59.72$3,145,930.16View SEC Filing  
5/28/2015Heino LennartzInsiderSell9,584$55.00$527,120.00View SEC Filing  
5/22/2015Karen FlynnInsiderSell3,091$55.24$170,746.84View SEC Filing  
5/21/2015Eric Mark GreenCEOBuy18,300$54.89$1,004,487.00View SEC Filing  
5/18/2015Karen FlynnInsiderSell1,909$55.00$104,995.00View SEC Filing  
5/15/2015Donald E Morel JrCEOSell20,000$54.29$1,085,800.00View SEC Filing  
2/27/2015Richard D LuzziVPSell10,000$54.85$548,500.00View SEC Filing  
2/26/2015Michael A AndersonVPSell4,682$54.93$257,182.26View SEC Filing  
2/25/2015Heino LennartzInsiderSell3,617$54.82$198,283.94View SEC Filing  
2/24/2015John E PaproskiInsiderSell9,282$52.87$490,739.34View SEC Filing  
2/23/2015Heino LennartzInsiderSell21,040$53.40$1,123,536.00View SEC Filing  
2/23/2015Patrick J ZennerDirectorSell12,800$53.69$687,232.00View SEC Filing  
11/26/2014Richard D LuzziVPSell8,000$52.11$416,880.00View SEC Filing  
11/21/2014William J FedericiCFOSell3,000$51.22$153,660.00View SEC Filing  
11/20/2014Donald E Morel JrCEOSell20,000$51.30$1,026,000.00View SEC Filing  
11/13/2014John R GaileyVPSell28,000$52.37$1,466,360.00View SEC Filing  
11/11/2014Michael A AndersonVPSell4,600$51.73$237,958.00View SEC Filing  
11/10/2014Warwick BedwellInsiderSell6,306$49.95$314,984.70View SEC Filing  
8/21/2014Richard D LuzziVPSell10,000$44.07$440,700.00View SEC Filing  
8/20/2014John R GaileyVPSell20,000$43.96$879,200.00View SEC Filing  
8/19/2014Michael A AndersonVPSell9,800$43.41$425,418.00View SEC Filing  
8/18/2014William J FedericiCFOSell38,366$42.56$1,632,856.96View SEC Filing  
8/13/2014Heino LennartzInsiderSell7,555$39.65$299,555.75View SEC Filing  
8/11/2014Heino LennartzInsiderSell11,445$40.00$457,800.00View SEC Filing  
8/7/2014John E PaproskiInsiderSell14,000$40.44$566,160.00View SEC Filing  
5/30/2014Richard D LuzziVPSell22,828$42.17$962,656.76View SEC Filing  
5/29/2014Heino LennartzInsiderSell2,000$43.00$86,000.00View SEC Filing  
2/28/2014Heino LennartzInsiderSell16,044$45.84$735,456.96View SEC Filing  
2/26/2014Patrick J ZennerDirectorSell12,800$46.12$590,336.00View SEC Filing  
2/24/2014Warwick BedwellInsiderSell24,606$47.49$1,168,538.94View SEC Filing  
11/26/2013Donald E Morel JrCEOSell35,000$48.60$1,701,000.00View SEC Filing  
11/22/2013William J FedericiCFOSell36,000$48.34$1,740,240.00View SEC Filing  
11/19/2013Karen FlynnInsiderSell5,500$47.75$262,625.00View SEC Filing  
11/8/2013Michael A AndersonVPSell9,200$46.80$430,560.00View SEC Filing  
11/7/2013Heino LennartzInsiderSell5,102$46.70$238,263.40View SEC Filing  
11/6/2013Michael A AndersonVPSell6,000$46.53$279,180.00View SEC Filing  
11/5/2013John R GaileyVPSell6,000$46.83$280,980.00View SEC Filing  
11/5/2013Warwick BedwellInsiderSell6,304$46.84$295,279.36View SEC Filing  
11/4/2013Richard D LuzziVPSell38,708$46.99$1,818,888.92View SEC Filing  
8/30/2013Donald E Morel JrCEOSell10,000$74.46$744,600.00View SEC Filing  
8/27/2013John R GaileyVPSell13,749$76.77$1,055,510.73View SEC Filing  
8/22/2013L Robert JohnsonDirectorSell1,883$76.81$144,633.23View SEC Filing  
8/14/2013John E PaproskiInsiderSell6,011$79.08$475,349.88View SEC Filing  
8/12/2013Anthony WeltersDirectorSell19,200$78.43$1,505,856.00View SEC Filing  
8/8/2013Michael A AndersonVPSell4,300$78.00$335,400.00View SEC Filing  
5/31/2013Michael A AndersonVPSell4,000$68.94$275,760.00View SEC Filing  
5/28/2013Donald E Morel JrCEOSell10,000$67.87$678,700.00View SEC Filing  
5/24/2013L Robert JohnsonDirectorSell1,700$67.47$114,699.00View SEC Filing  
5/20/2013John R GaileyVPSell9,282$68.54$636,188.28View SEC Filing  
5/17/2013L Robert JohnsonDirectorSell4,000$67.80$271,200.00View SEC Filing  
5/8/2013L Robert JohnsonDirectorSell6,400$64.49$412,736.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

West Pharmaceutical Services (NYSE WST) News Headlines

Source:
DateHeadline
What does West Pharmaceutical Services Inc’s (WST) Balance Sheet Tell Us Abouts Its Future?What does West Pharmaceutical Services Inc’s (WST) Balance Sheet Tell Us Abouts Its Future?
finance.yahoo.com - December 11 at 4:34 PM
West Pharmaceutical Services, Inc. (WST) Expected to Announce Quarterly Sales of $415.53 MillionWest Pharmaceutical Services, Inc. (WST) Expected to Announce Quarterly Sales of $415.53 Million
www.americanbankingnews.com - December 2 at 4:58 AM
West Pharmaceutical Services, Inc. (WST) Given Average Recommendation of "Hold" by BrokeragesWest Pharmaceutical Services, Inc. (WST) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - November 22 at 1:34 AM
Former Partner Rachael M. Bushey Rejoins Pepper Hamilton as Chair of Life Sciences and Vice Chair of Health Sciences DepartmentFormer Partner Rachael M. Bushey Rejoins Pepper Hamilton as Chair of Life Sciences and Vice Chair of Health Sciences Department
feeds.benzinga.com - November 21 at 11:58 AM
West Pharmaceutical (WST) Presents At Jefferies 2017 London Healthcare Conference - SlideshowWest Pharmaceutical (WST) Presents At Jefferies 2017 London Healthcare Conference - Slideshow
seekingalpha.com - November 18 at 10:23 AM
ETFs with exposure to West Pharmaceutical Services, Inc. : November 14, 2017ETFs with exposure to West Pharmaceutical Services, Inc. : November 14, 2017
finance.yahoo.com - November 16 at 8:42 AM
West Announces Upcoming Investor ConferenceWest Announces Upcoming Investor Conference
finance.yahoo.com - November 16 at 8:42 AM
Head to Head Contrast: West Pharmaceutical Services (WST) and Its RivalsHead to Head Contrast: West Pharmaceutical Services (WST) and Its Rivals
www.americanbankingnews.com - November 8 at 3:56 PM
West Pharmaceutical Services’ (WST) Robust Earnings Growth Make it a BuyWest Pharmaceutical Services’ (WST) Robust Earnings Growth Make it a Buy
investorplace.com - November 7 at 7:33 PM
West Pharmaceutical Services’ (WST) Robust Earnings Growth Make it a BuyWest Pharmaceutical Services’ (WST) Robust Earnings Growth Make it a Buy
investorplace.com - November 7 at 7:09 PM
Cardiovascular Systems (CSII) and West Pharmaceutical Services (WST) Financial AnalysisCardiovascular Systems (CSII) and West Pharmaceutical Services (WST) Financial Analysis
www.americanbankingnews.com - November 7 at 3:28 AM
Reviewing Cardiovascular Systems (CSII) and West Pharmaceutical Services (WST)Reviewing Cardiovascular Systems (CSII) and West Pharmaceutical Services (WST)
www.americanbankingnews.com - November 6 at 9:26 PM
West to Showcase New Extensions of the SmartDose® Drug Delivery Platform at the PDA Universe of Pre-filled Syringes and Injection DevicesWest to Showcase New Extensions of the SmartDose® Drug Delivery Platform at the PDA Universe of Pre-filled Syringes and Injection Devices
finance.yahoo.com - November 6 at 9:37 AM
ETFs with exposure to West Pharmaceutical Services, Inc. : November 3, 2017ETFs with exposure to West Pharmaceutical Services, Inc. : November 3, 2017
finance.yahoo.com - November 5 at 8:18 AM
West Pharmaceutical Services, Inc. :WST-US: Earnings Analysis: Q3, 2017 By the Numbers : November 2, 2017West Pharmaceutical Services, Inc. :WST-US: Earnings Analysis: Q3, 2017 By the Numbers : November 2, 2017
finance.yahoo.com - November 2 at 11:37 AM
FY2017 EPS Estimates for West Pharmaceutical Services, Inc. (WST) Lifted by Jefferies GroupFY2017 EPS Estimates for West Pharmaceutical Services, Inc. (WST) Lifted by Jefferies Group
www.americanbankingnews.com - October 30 at 1:42 AM
West Pharmaceutical Services, Inc. (WST) Receives Consensus Recommendation of "Hold" from AnalystsWest Pharmaceutical Services, Inc. (WST) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - October 28 at 1:44 AM
West Pharmaceutical Services Inc. 2017 Q3 - Results - Earnings Call SlidesWest Pharmaceutical Services Inc. 2017 Q3 - Results - Earnings Call Slides
seekingalpha.com - October 27 at 4:57 PM
Stocks Flashing Renewed Technical Strength: West Pharmaceutical ServicesStocks Flashing Renewed Technical Strength: West Pharmaceutical Services
finance.yahoo.com - October 27 at 4:57 PM
West Pharmaceutical Services, Inc. breached its 50 day moving average in a Bullish Manner : WST-US : October 27, 2017West Pharmaceutical Services, Inc. breached its 50 day moving average in a Bullish Manner : WST-US : October 27, 2017
finance.yahoo.com - October 27 at 4:57 PM
West Pharmaceutical Services, Inc.: Leads amongst peers with strong fundamentalsWest Pharmaceutical Services, Inc.: Leads amongst peers with strong fundamentals
finance.yahoo.com - October 27 at 4:57 PM
Wells Fargo & Company Boosts West Pharmaceutical Services, Inc. (WST) Price Target to $112.00Wells Fargo & Company Boosts West Pharmaceutical Services, Inc. (WST) Price Target to $112.00
www.americanbankingnews.com - October 27 at 11:04 AM
Edited Transcript of WST earnings conference call or presentation 26-Oct-17 1:00pm GMTEdited Transcript of WST earnings conference call or presentation 26-Oct-17 1:00pm GMT
finance.yahoo.com - October 27 at 7:39 AM
West Pharmaceutical Services, Inc. (WST) Releases Quarterly  Earnings Results, Beats Estimates By $0.14 EPSWest Pharmaceutical Services, Inc. (WST) Releases Quarterly Earnings Results, Beats Estimates By $0.14 EPS
www.americanbankingnews.com - October 26 at 1:22 PM
West Pharmaceutical Services, Inc. (WST) Updates FY17 Earnings GuidanceWest Pharmaceutical Services, Inc. (WST) Updates FY17 Earnings Guidance
www.americanbankingnews.com - October 26 at 1:22 PM
West Announces Third-Quarter 2017 ResultsWest Announces Third-Quarter 2017 Results
finance.yahoo.com - October 26 at 9:13 AM
WEST PHARMACEUTICAL SERVICES INC to Host Earnings CallWEST PHARMACEUTICAL SERVICES INC to Host Earnings Call
finance.yahoo.com - October 26 at 9:13 AM
West Pharmaceutical tops Street 3Q forecastsWest Pharmaceutical tops Street 3Q forecasts
finance.yahoo.com - October 26 at 9:13 AM
West Pharmaceutical Services, Inc. : WST-US: Dividend Analysis : October 18th, 2017 (record date) : By the numbers : October 25, 2017West Pharmaceutical Services, Inc. : WST-US: Dividend Analysis : October 18th, 2017 (record date) : By the numbers : October 25, 2017
finance.yahoo.com - October 25 at 5:59 PM
Comparing Great Basin Scientific (GBSN) & West Pharmaceutical Services (WST)Comparing Great Basin Scientific (GBSN) & West Pharmaceutical Services (WST)
www.americanbankingnews.com - October 25 at 8:37 AM
CSE New Listing - Westridge Resources Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.comCSE New Listing - Westridge Resources Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com
finance.yahoo.com - October 24 at 12:31 PM
West Pharmaceutical Services, Inc. (WST) Set to Announce Quarterly Earnings on WednesdayWest Pharmaceutical Services, Inc. (WST) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - October 18 at 3:22 AM
Reviewing Align Technology (ALGN) & West Pharmaceutical Services (WST)Reviewing Align Technology (ALGN) & West Pharmaceutical Services (WST)
www.americanbankingnews.com - October 16 at 12:08 AM
Cash Dividend On The Way From West Pharmaceutical Services (WST)Cash Dividend On The Way From West Pharmaceutical Services (WST)
www.nasdaq.com - October 15 at 8:24 AM
West Pharmaceutical Services (WST) vs. Its Rivals Head-To-Head ContrastWest Pharmaceutical Services (WST) vs. Its Rivals Head-To-Head Contrast
www.americanbankingnews.com - October 13 at 4:28 AM
Short Interest Jumps 21.3% For WSTShort Interest Jumps 21.3% For WST
www.thestreet.com - October 12 at 10:15 AM
West to Host Third-Quarter 2017 Conference CallWest to Host Third-Quarter 2017 Conference Call
finance.yahoo.com - October 12 at 10:15 AM
CGOV Asset Management Buys Canadian Pacific Railway, Starbucks Corp, Cisco Systems Inc, Sells ...CGOV Asset Management Buys Canadian Pacific Railway, Starbucks Corp, Cisco Systems Inc, Sells ...
www.nasdaq.com - October 11 at 9:42 AM
Analyzing Bio-Rad Laboratories (BIO) and West Pharmaceutical Services (WST)Analyzing Bio-Rad Laboratories (BIO) and West Pharmaceutical Services (WST)
www.americanbankingnews.com - October 9 at 8:10 AM
$0.53 Earnings Per Share Expected for West Pharmaceutical Services, Inc. (WST) This Quarter$0.53 Earnings Per Share Expected for West Pharmaceutical Services, Inc. (WST) This Quarter
www.americanbankingnews.com - October 4 at 10:24 AM
IBD Rating Upgrades: West Pharmaceutical Services Flashes Improved Technical StrengthIBD Rating Upgrades: West Pharmaceutical Services Flashes Improved Technical Strength
finance.yahoo.com - October 3 at 3:15 PM
West Pharmaceutical Services Shows Improved Relative Price Performance; Still Shy Of BenchmarkWest Pharmaceutical Services Shows Improved Relative Price Performance; Still Shy Of Benchmark
finance.yahoo.com - October 3 at 3:15 PM
West Pharmaceutical Services, Inc. (WST) Now Covered by StephensWest Pharmaceutical Services, Inc. (WST) Now Covered by Stephens
www.americanbankingnews.com - October 3 at 1:32 PM
West Pharmaceutical Services, Inc. (WST) Given Average Rating of "Hold" by BrokeragesWest Pharmaceutical Services, Inc. (WST) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - October 3 at 10:50 AM
West Pharmaceutical Services, Inc. (WST) Sees Large Growth in Short InterestWest Pharmaceutical Services, Inc. (WST) Sees Large Growth in Short Interest
www.americanbankingnews.com - October 3 at 3:32 AM
Contrasting DENTSPLY SIRONA (XRAY) and West Pharmaceutical Services (WST)Contrasting DENTSPLY SIRONA (XRAY) and West Pharmaceutical Services (WST)
www.americanbankingnews.com - October 2 at 12:22 PM
Jefferies Group Equities Analysts Raise Earnings Estimates for West Pharmaceutical Services, Inc. (WST)Jefferies Group Equities Analysts Raise Earnings Estimates for West Pharmaceutical Services, Inc. (WST)
www.americanbankingnews.com - September 18 at 4:50 AM
Zimmer Biomet Holdings (ZBH) and West Pharmaceutical Services (WST) Head-To-Head ReviewZimmer Biomet Holdings (ZBH) and West Pharmaceutical Services (WST) Head-To-Head Review
www.americanbankingnews.com - September 17 at 8:26 AM
West Pharmaceutical Services, Inc. (WST) Upgraded by Jefferies Group LLC to "Buy"West Pharmaceutical Services, Inc. (WST) Upgraded by Jefferies Group LLC to "Buy"
www.americanbankingnews.com - September 16 at 12:26 AM
 Analysts Set $102.75 Target Price for West Pharmaceutical Services, Inc. (WST) Analysts Set $102.75 Target Price for West Pharmaceutical Services, Inc. (WST)
www.americanbankingnews.com - September 15 at 10:36 PM

SEC Filings

West Pharmaceutical Services (NYSE:WST) SEC Filings

DateFilerForm TypeView
12/05/2017
5:12 PM
MILLER GEORGE LLOYD (Reporting)
West Pharmaceutical Services (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/05/2017
5:08 PM
Flynn Karen (Reporting)
West Pharmaceutical Services (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing

Social Media

Financials

West Pharmaceutical Services (NYSE:WST) Income Statement, Balance Sheet and Cash Flow Statement

Chart

West Pharmaceutical Services (NYSE WST) Stock Chart for Monday, December, 11, 2017

Loading chart…

This page was last updated on 12/11/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.